[The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
The paper presents the results of diagnostic and therapeutic use of intracavernous injections of alprostadil edex (prostaglandin E1) of Schwartz Pharma AG production (Germany) in 14 patients with functional, compensated and subcompensated organic erectile dysfunction. Pharmacological test with alprostadil modelling cavernous body function extends diagnostic efficacy of doppler scanning of the penis and cavernosography. A complete effect (100% sexual rehabilitation) was achieved in 1 and partial in 3 males. Alprostadil edex kits are advocated as safe and convenient.
Mzo
E B
EB
Dmitriev
D G
DG
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage*; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects; D010413:Penis / Q000098:blood supply; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D000527:Alprostadil
Lechebno-diagnosticheskie vozmozhnosti intrakavernoznogo primeneniia al'prostadila "Edeks" u bol'nykh s érektil'noĭ disfunktsieĭ.